drugset / Trial / NCT00674154

Effect of Vitamin D Treatment in Primary Hyperparathyroidism

NCT00674154

Phase 2/3 Completed 46 enrolled University of Aarhus
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary aim of the study is to assess whether 6-months of vitamin D supplements can decrease PTH compared with placebo treatment in primary hyperparathyroidism.

Timeline

Start
2008-05
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 2800 iu Oral